Extendicare (EXE) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
1 Jun, 2026Strategic positioning and growth drivers
Largest seniors' care provider in Canada, focused on long-term and home health care, with 58 years of experience and a strong acquisition pipeline in a fragmented market.
Over 90% of revenue comes from government contracts, providing revenue stability and insulation from economic cycles.
Capital-efficient growth through a joint venture with Axium Infrastructure, enabling expansion of long-term care homes with minimal capital requirements.
Strong balance sheet with low leverage (pro forma debt to adjusted EBITDA ~2.8x) and significant available liquidity (~$228M).
Annual dividend per share of $0.5292 and a payout ratio of ~41%.
Market opportunity and demographic trends
Canadian seniors aged 85+ are growing at ~4% per year, with a projected need for over 200,000 new LTC beds by 2035.
Ontario's LTC bed ratio has declined from 99 to 57 beds per 1,000 people aged 75+ since 2006, with a waitlist exceeding 50,000.
Home health care volumes are growing faster than the seniors' population, helping bridge the LTC shortfall.
Business segments and performance
Home health care segment delivered 14.5M ParaMed hours and added ~10M hours from CBI Home Health, with adjusted NOI margin at a multi-year high of 13.5%.
Long-term care segment operates 59 fully owned homes (8,147 beds), with occupancy above 98% and adjusted NOI margin at 11.6%.
Managed services (Extendicare Assist and SGP) serve ~157,100 beds, with consistent NOI margins of 50-55%.
Latest events from Extendicare
- Q1 2026 saw 52% EBITDA growth, major acquisitions, and strong Home Healthcare expansion.EXE
Q1 202614 May 2026 - Financial growth, expanded care, and all proposals approved amid sector and integration challenges.EXE
AGM 202626 Apr 2026 - Strong 2025 growth, 5% dividend hike, and $570M CBI Home Health acquisition set for Q2 2026.EXE
Q4 20256 Apr 2026 - Adjusted EBITDA up 42.7% year-over-year, driven by home health care and managed services growth.EXE
Q1 202531 Mar 2026 - Q2 2024 delivered strong revenue, margin growth, and robust progress in redevelopment.EXE
Q2 20241 Feb 2026 - Double-digit revenue and margin growth, with enhanced liquidity and redevelopment progress.EXE
Q3 202414 Jan 2026 - Q4 2024 saw strong growth, margin gains, and a 5% dividend hike amid robust demand.EXE
Q4 20241 Dec 2025 - All proposals passed, with a 5% dividend hike and major growth and governance initiatives.EXE
AGM 202526 Nov 2025 - Q2 2025 delivered 15.4% EBITDA growth and expansion from major acquisitions and home health care.EXE
Q2 202523 Nov 2025